Umckalor pills p/o 20mg №15×1

Name:
Umckalor solution for oral administration in a bottle. 20 ml in pack No. 1
Description:
Round, reddish-brown tablets, film-coated. Release form film-coated tablets Dosage 20 mg Indications for use Symptomatic treatment of acute bronchitis. Dosage and administration Adults and children over 12 years old: 1 film-coated tablet 3 times a day (morning, afternoon and evening). Umckalor is recommended to be taken without chewing, with a small amount of liquid. In addition, in order to prevent relapse, treatment with the drug is recommended to continue for several more days after the symptoms of the disease disappear. The duration of treatment should not exceed 3 weeks. Use during pregnancy and lactation It is not recommended to take the drug during pregnancy and lactation, due to insufficient data on safety during pregnancy and lactation. Precautions The patient should consult a doctor if his condition does not improve within one week, in case of fever lasting for several days, shortness of breath or bloody sputum. Umckalor is not recommended for use in children under 12 years of age. It is not recommended to use the drug in patients with rare hereditary diseases of galactose intolerance, lactase deficiency or glucose-galactose malabsorption. Interaction with other drugs No drug interactions are known so far. In view of the possible effect of the drug Umckalor on blood coagulation parameters, it is possible that, with simultaneous use, it can affect the effect of such indirect anticoagulants as warfarin. A placebo-controlled, double-blind study in healthy volunteers showed no interaction between Pelargonium extract and penicillin V. Contraindications Hypersensitivity to the active substance or to any of the excipients; Increased tendency to bleed and use of anticoagulants; sufficient application experience. Composition 1 film-coated tablet contains: active substances: 20 mg of dried liquid extract from the roots of Pelargonium sidoides (Pelargonium sidoides) (1: 8-10), extractant: ethanol 11 vol. %. excipients: maltodextrin; cellulose microcrystalline; lactose monohydrate; croscarmellose sodium; silicon dioxide precipitated; magnesium stearate; shell composition: hypromelose 5 MPa; macrogol 1500; iron oxide yellow E 172; iron oxide red E 172; titanium dioxide E 171; talc; antifoam emulsion: simethicone, methylcellulose, sorbic acid. Side effect Very often (?1/10) Often (?1/100 – <1/10) Infrequently (?1/1000 - <1/100) Rarely (?1/10000 - <1/1000) Very rare (<1/10 000) Not known (Frequency cannot be estimated from the available data) Gastrointestinal disorders: infrequently: gastrointestinal disorders; rarely: slight bleeding of the gums Respiratory, thoracic and mediastinal disorders: rarely: mild nosebleeds Skin and subcutaneous disorders/immune system disorders: rarely: hypersensitivity reactions Hepatobiliary disorders: very rarely: increased liver values; there is no direct causal relationship between these indicators and the use of the product. Storage conditions The drug does not require special storage conditions. Keep out of the reach of children. Buy Umckalor pills p/o 20mg No. 15x1 Price for Umckalor pills p/o 20mg No. 15x1